Clinical Trial Update: Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023) [Phase 2]

View source ↗

Summary

An extension-study trial update for sotatercept in people with pulmonary hypertension, currently in Phase 2 and recruiting (MK-7962-023).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension, Pulmonary | Phase 2 | Status: RECRUITING